Protecting newborns from pertussis - the challenge of complete cocooning

Pascal Urwyler, Ulrich Heininger1

  • 1Division of Pediatric Infectious Diseases, University Children's Hospital Basel (UKBB), Spitalstrasse 33, PO Box, CH 4031 Basel, Switzerland. ulrich.heininger@ukbb.ch.

Insights

The pertussis cocoon strategy for newborns is challenging to implement, with most families having incomplete vaccination coverage among close contacts. Improving pertussis immunization rates is crucial for protecting infants.

Area of Science:

  • Public Health
  • Immunology
  • Pediatrics

Background:

  • Rising pertussis (whooping cough) cases pose a significant threat to young infants.
  • The cocoon strategy, involving immunization of close contacts, was implemented in Switzerland in 2011 to protect newborns.
  • Assessing parental knowledge and the effectiveness of this strategy is vital.

Purpose of the Study:

  • To evaluate parental knowledge regarding pertussis.
  • To assess the acceptance, practicality, and implementation of the pertussis cocoon strategy in Switzerland.
  • To identify barriers and facilitators for successful cocooning.

Main Methods:

  • A cross-sectional survey was conducted among parents of newborns in Basel city and country.
  • A standardized questionnaire was mailed to eligible families.
  • Statistical analyses, including Pearson's chi-squared test, were used to compare proportions.

Main Results:

  • Only 37% of parents answered all pertussis knowledge questions correctly.
  • Mothers and fathers reported varying rates of recommendation for pertussis immunization.
  • Cocooning remained incomplete in 93% of families, with less than 50% of close contacts vaccinated.

Conclusions:

  • Implementing the pertussis cocoon strategy is challenging, often resulting in incomplete vaccination coverage.
  • Healthcare providers should universally recommend cocooning to improve infant protection.
  • Promoting pertussis immunization, including for pregnant women, is essential for optimal newborn safety.
Abstract

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.7K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
5.0K
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
169
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.1K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
978